Pharma Journalist -

Regeneron Pharmaceuticals, Inc. announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron's investigational double antibody cocktail for the treatment and…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced topline results from study SEP380-201, a global, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to…
Read More...

SMi reports: SMi are pleased to inform you that Matthew Catley from MiNa Therapeutics Ltd has confirmed his position as speaker SMi are pleased to inform you that Matthew Catley,…
Read More...

Unum Therapeutics Inc. announced it has completed the acquisition of Kiq LLC, a privately held, biotechnology company focused on the discovery and development of precision kinase…
Read More...

Medivir AB announced that it has entered a research collaboration with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2. Through the…
Read More...

Emergent BioSolutions Inc. announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson &…
Read More...

Mylan N.V. announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI's accelerated…
Read More...

HitGen Inc. announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by…
Read More...

Ascentage Pharma, a global, clinical-stage biotechnology company developing novel therapies for cancers, chronic hepatitis B (CHB), and senesce diseases, announced a clinical…
Read More...

SMi Reports: Featured Speakers listed for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. The global wearable devices market size…
Read More...